RiaSTAP (CSL Behring GmbH)
Welcome to the PulseAid listing for the RiaSTAP drug offered from CSL Behring GmbH. This Human Blood Coagulation Factor [EPC],Increased Coagulation Activity [PE],Blood Coagulation Factors [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | CSL Behring GmbH |
| NON-PROPRIETARY NAME: | FIBRINOGEN HUMAN |
| SUBSTANCE NAME: | FIBRINOGEN HUMAN |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | Human Blood Coagulation Factor [EPC],Increased Coagulation Activity [PE],Blood Coagulation Factors [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2009-01-16 |
| END MARKETING DATE: | 0000-00-00 |
RiaSTAP PLASMA DERIVATIVE Details:
| Item Description | RiaSTAP from CSL Behring GmbH |
| LABELER NAME: | CSL Behring GmbH |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1300(mg/50mL) |
| START MARKETING DATE: | 2009-01-16 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63833-891_b9fd1cc1-5a93-4161-8b06-d0476209de6f |
| PRODUCT NDC: | 63833-891 |
| APPLICATION NUMBER: | BLA125317 |
Other FIBRINOGEN HUMAN Pharmaceutical Manufacturers / Labelers:
